Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

enue to be between $520 million and $550 million
  • Reported (GAAP) diluted earnings per share to be between $2.22 and $2.32
  • Adjusted diluted earnings per share to be between $4.55 and $4.65

  • The company's 2011 guidance is based on certain assumptions including:

  • Adjusted gross margin of between 69% and 71%
  • Adjusted effective tax rate of approximately 28%
  • Weighted average number of common shares outstanding of 123 million shares for the year ended December 31, 2011; and
  • No generic competition for Voltaren Gel in 2011

  • Selected Operating HighlightsOpana® ER Complete ResponseOn June 23, 2011, Endo Pharmaceuticals announced that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of Opana ER has been accepted.  The new formulation was developed in partnership with Grunenthal GmbH and is designed to provide some resistance to certain types of product manipulation.  FDA has set a Prescription Drug User Fee Act (PDUFA) date of Dec. 13, 2011.

    Completion of Acquisition of American Medical SystemsOn June 17, 2011, Endo Pharmaceuticals acquired American Medical Systems, Inc. (AMS), for approximately $2.9 billion. AMS brings Endo scale in its device and services business segment, and the combination of AMS with Endo's existing platform will provide additional cost-effective solutions across the entire urology spectrum.  It is expected that the combined company will deliver more comprehensive healthcare solutions across its diversified business in branded pharmaceuticals, generics, and devices and services in key therapeutic areas including pain and urology.

    Pricing of Private Offering of Senior Notes and 2011 Credit FacilityOn June 3, 2011, Endo Pharmaceuticals announced that it priced $500 million aggregate prin
    '/>"/>

    SOURCE Endo Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... , Chine, 3 juillet 2015 BGI a ... haut débit de l,ADN situé à ... de  l,American College of Pathologists  (Collège des pathologistes ... Hong Kong constituent le ... à recevoir la certification du CAP en Chine, ...
    (Date:7/2/2015)...  New product launches are critical events for the ... thought leaders about new products, Medical Affairs is one ... a new therapy performs at launch. ... leader Best Practices, LLC, critical aspects of launch support ... early stage thought leader (TL) interaction, successful TL targeting, ...
    (Date:7/2/2015)... 2015 Roche,s Bloodhound technology is on ... in hematology testing, according to Kalorama Information.  The ... of its Bloodhound digital cell imaging technology –as ... hematology analyzer – is notable as a ... current leader CellaVision, but also compete more broadly ...
    Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
    ... , , DERMATOLOGISTS CAN ... , BOSTON, July 29 For many women, their hair ... to long, cascading curls, the right hairstyle can make any woman look ... That,s why hair loss can be particularly devastating for women, and dermatologists ...
    ... , , NEWPORT ... announced promising data from a clinical study showing patient-specific cancer ... were well tolerated and resulted in impressive long-term survival rates ... by other therapies. , , ...
    Cached Medicine Technology:Is Your Hair Taking a Break? 2Is Your Hair Taking a Break? 3Is Your Hair Taking a Break? 4Is Your Hair Taking a Break? 5Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy 2Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy 3
    (Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national president recruitment ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
    (Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO ... Emergency Room , the largest network of independent freestanding emergency rooms in the United ... director of our Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency ...
    (Date:7/3/2015)... ... 2015 , ... The Celebrity Dresses is currently running a promotion through July ... will have the opportunity to get 10% discount on orders that are over $100. ... have to use coupon codes or remember redemption codes. , There is a ...
    (Date:7/2/2015)... ... 02, 2015 , ... The American Association of Poison Control ... Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with the ... decrease drug overdose – especially of heroin and opioid medication – by expanding ...
    (Date:7/2/2015)... ... 2015 , ... “ LIFX ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... bulbs on the market. , According to the U.S. Department of Energy, it’s very ...
    Breaking Medicine News(10 mins):Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
    ... Bionovo, Inc. (Nasdaq: BNVI ) announced today that ... fiscal year 2009 ended March 31, 2009 on Thursday, May ... webcast to review the financial results on Thursday, May 7, ... by dialing (877) 356-5706 or (706) 643-0580, or can listen ...
    ... Incentives Driving Increased Utilization of ePrescribing within ... Glen Tullman Testifies Before National Committee on ... Allscripts announced today that, for the second ... over the Surescripts network than any other ...
    ... How long would it take to walk across the ... of South Carolina,s community events marking National Walk @ ... lunch breaks.An estimated 3,000 people turned out for lunchtime ... in Charleston, and Falls Park in Greenville, and together ...
    ... Nursing Home, Assisted Living, Home Care and Adult Day Health ... April 30 The cost of long term ... putting significant financial pressure on those in or near retirement, ... the same time, the current economic downturn has led to ...
    ... Nursing Home, Assisted Living, Home Care and Adult Day Health ... April 30 The cost of long term ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has ...
    ... Assisted Living, Home Care and Adult Day Health Care Costs ... The cost of long term care in Utah ... pressure on those in or near retirement, according to an ... the current economic downturn has led to a decline in ...
    Cached Medicine News:Health News:Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009 2Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 2Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 3Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 4Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 5Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 6Health News:Columbia, Greenville, Charleston Walkers Cover 3,000 Miles During Lunch 2Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Washington Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Washington Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Washington Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Utah Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Utah Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Utah Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4
    ... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
    Extra-large 3.2mm channel allows excellent suction with EndoTherapy devices in place....
    ... bronchofiberscope yet. The BF-3C40's distal end measures ... the previous model. It also offers better ... to the use of extra-fine optical fibers ... size by 70 percent. Images are clearer, ...
    Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
    Medicine Products: